Bovine tuberculosis

(Barry) #1

218 B.M. Buddle et al.


The field testing of BCG vaccine in possums
and badgers administered via oral or parenteral
routes have resulted in the induction of signifi-
cant levels of protection in these animals and a
parenteral BCG vaccine has now been licensed
for use in badgers in the UK. In wild boar, both
BCG and killed M. bovis vaccines have been
shown to protect these animals against TB and
the killed M. bovis vaccine is in the process of
being tested in other wildlife species as well. Oral
bait TB vaccines have been shown to be effective
in a number of wildlife species, but more
research is necessary to improve formulations
with appropriate attractants, systems for opti-
mizing bait distribution and avoiding bait uptake
by non-target species. In summary, there have


been major advances in the development and
testing of TB vaccines for domestic and wild ani-
mals in the past 5 to 10 years, and it is now
becoming more certain that TB vaccines will
play an important role in the control of bovine
TB in the near future.

Acknowledgements

Funding has been received from AgResearch
(New Zealand) and the Department of Environ-
ment, Food and Rural Affairs (UK). Research on
heat-inactivated M. bovis is supported by Plan
Nacional I+D+i grant AGL2014-56305 from
MINECO, Spain and EU FEDER.

References

Aagaard, C., Hoang, T.T., Izzo, A., Billeskov, R., Troudt, J., et al. (2009) Protection and polyfunctional T
cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the
antigen dose. PLoS ONE 4, e5930.
Abdou, M., Frankena, K., O’Keeffe, J. and Byrne, A.W. (2016) Effect of culling and vaccination on bovine
tuberculosis infection in a European badger (Meles meles) population by spatial simulation modelling.
Preventive Veterinary Medicine 125, 19–30.
Aldwell, F.E., Keen, D., Parlane, N., Skinner, M.A., de Lisle, G.W., et al. (2003) Oral vaccination with Myco-
bacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in possums.
Vaccine 22, 70–76.
Ameni, G., Vordermeier, M., Aseffa, A., Young, D.B. and Hewinson, R.G. (2010) Field evaluation of the
efficacy of Mycobacterium bovis bacillus Calmette–Guérin against bovine tuberculosis in neonatal
calves in Ethiopia. Clinical and Vaccine Immunology 17, 1533–1538.
Aranday-Cortes, E., Hogarth, P.J., Kaveh, D.A., Whelan, A.O., Villarreal-Ramos, B., et al. (2012) Tran-
scriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of
potential diagnostic biomarkers. PLoS One 7, e30626.
Barasona, J.A., Torres, M.J., Aznar, J., Gortazar, C. and Vicente, J. (2016) DNA detection reveals Myco-
bacterium tuberculosis complex shedding routes in its wildlife reservoir the Eurasian wild boar. Trans-
boundary and Emerging Diseases 64(3), 906–915.
Beatson, N.S. (1985) Tuberculosis in red deer. In: Brown, R.D. (ed.) Biology of Deer Production. Springer,
New York, pp. 147–150.
Beltrán-Beck, B., De La Fuente, J., Garrido, J.M., Aranaz, A., Sevilla, I., et al. (2014a) Oral vaccination with
heat inactivated Mycobacterium bovis activates the complement system to protect against tuberculo-
sis. PLoS ONE 9(5), e98048.
Beltrán-Beck, B., Romero, B., Sevilla, I., Barasona, J.A., Garrido, J.M., et al. (2014b) Assessment of an
oral Mycobacterium bovis BCG vaccine and an inactivated M. bovis preparation for wild boar in terms
of adverse reactions, vaccine strain survival, and uptake by nontarget species. Clinical and Vaccine
Immunology 21, 12–20.
Bezos, J., Casal, C., Diez-Delgado, I., Romero, B., Liandris, E., et al. (2015) Goats challenged with differ-
ent members of the Mycobacterium tuberculosis complex display different clinical pictures. Veterinary
Immunology and Immunopathology 167, 185–189.
Bhuju, S., Aranday-Cortes, E., Villarreal-Ramos, B., Xing, Z., Singh, M., et al. (2012) Global gene tran-
scriptome analysis in vaccinated cattle revealed a dominant role of IL-22 for protection against bovine
tuberculosis. PLoS Pathogens 8, e1003077.

Free download pdf